Friday, October 28, 2011 1:46:56 PM
Guys, I'm afraid there's no better way to say it:
We just got "PIPED!"-
but I'm adding too.
Just glad I hadn't built too big a position before this.
I guess that director sell at 1.25 a few months ago was the tell-
he had to know this was coming.
As for the long positions held by other officers, I'm sure they can absorb the loss via warrant issuance from this offering, stock option grants, and such.
The learning curve in these things can, unfortunately, be a long one.
I guess my concern, going forward, is/will be the warrant overhang.
Anyone have any idea how many may be lingering out there from previous financings?
BTW, thanks for the event calendar Don.
Somewhat comforting to bear in mind at such times.
Despite how it may sound, I'm not really bleak on the future here-
have certainly been here before with Ariad, and take a relatively long view.
Best regards all,
bw
We just got "PIPED!"-
but I'm adding too.
Just glad I hadn't built too big a position before this.
I guess that director sell at 1.25 a few months ago was the tell-
he had to know this was coming.
As for the long positions held by other officers, I'm sure they can absorb the loss via warrant issuance from this offering, stock option grants, and such.
The learning curve in these things can, unfortunately, be a long one.
I guess my concern, going forward, is/will be the warrant overhang.
Anyone have any idea how many may be lingering out there from previous financings?
BTW, thanks for the event calendar Don.
Somewhat comforting to bear in mind at such times.
Despite how it may sound, I'm not really bleak on the future here-
have certainly been here before with Ariad, and take a relatively long view.
Best regards all,
bw
Recent CPRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 09:23:18 PM
- Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance • GlobeNewswire Inc. • 02/25/2026 09:07:55 PM
- Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference • GlobeNewswire Inc. • 02/24/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 10:04:15 PM
- Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:03:17 PM
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies • GlobeNewswire Inc. • 01/08/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:30 PM
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) • GlobeNewswire Inc. • 01/05/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:15 PM
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/15/2025 01:03:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2025 09:25:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2025 10:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/26/2025 06:54:26 PM
